Michael S Abrams insider trades

Open-market stock purchases and sales by Michael S Abrams, Chief Financial Officer at NRX Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 31, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • NRXP NRX Pharmaceuticals, Inc: other filings, last Feb 7, 2025
  • ARTH Arch Therapeutics, Inc: 1 buy, last Aug 31, 2023
  • FTLF Fitlife Brands, Inc: 1 buy, last Feb 23, 2015
  • BNLB.OB Bond Laboratories, Inc: 1 buy, last Jan 16, 2013

Get free alerts when Michael S Abrams files a new trade →